Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

4001-4010 of 4090 results

Catalogue Number:

PX-TA1190

Category:

G

Urtoxazumab Biosimilar – Anti-Stx-2/ SLT-II mAb – Research Grade

Target: Stx-2/ SLT-II
Target Alias Name: Urtoxazumab/HuVTm1.1/TMA-15/Stx-2/ SLT-II/anti-Stx-2/ SLT-II
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA2146

Category:

G

Usilnetug Biosimilar – Anti-AICD-57 mAb – Research Grade

Target: AICD-57
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1011

Category:

G

Ustekinumab Biosimilar – Anti-Human IL-12 IL-23 mAb – Research Grade

Target: Human IL-12 IL-23
Target Alias Name: Ustekinumab/Ustekinumab/Human IL-12 IL-23/anti-Human IL-12 IL-23
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1012

Category:

G

Utomilumab Biosimilar – Anti-Human TNFRSF9 mAb – Research Grade

Target: Human TNFRSF9
Target Alias Name: Utomilumab/Utomilumab/Human TNFRSF9/anti-Human TNFRSF9
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1420

Category:

G

Vadastuximab Biosimilar – Anti-CD33/ SIGLEC3 mAb – Research Grade

Target: CD33/ SIGLEC3
Target Alias Name: Vadastuximab/h2H12ec/CD33/ SIGLEC3/anti-CD33/ SIGLEC3
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1911

Category:

G

VAK-694 Biosimilar – Anti-Binetrakin mAb – Research Grade

Target: Binetrakin
Target Alias Name: anti-Binetrakin/B-cell stimulatory factor 1/Pitrakinra/Lymphocyte stimulatory factor 1/IL-4/BSF-1/IL4/Interleukin-4/VAK-694/ NVP-VAK-694
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1734

Category:

G

Valanafusp Biosimilar – Anti-INSR mAb – Research Grade

Target: INSR
Target Alias Name: Valanafusp/AGT-181/ VALANAFUSP ALFA/INSR/anti-INSR
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1975

Category:

G

Vamikibart Biosimilar – Anti-Hybridoma growth factor mAb – Research Grade

Target: Hybridoma growth factor
Target Alias Name: anti-Hybridoma growth factor/ BSF-2/ IFN-beta-2/ CDF/ IL6/ Interleukin-6/ IL-6/ B-cell stimulatory factor 2/ Interferon beta-2/ IFNB2/ CTL differentiation factor
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG2-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1735

Category:

G

Vanalimab Biosimilar – Anti-CD40 mAb – Research Grade

Target: CD40
Target Alias Name: Vanalimab//CD40/anti-CD40
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

PX-TA1370

Category:

G

Vandortuzumab Biosimilar – Anti-STEAP1 mAb – Research Grade

Target: STEAP1
Target Alias Name: Vandortuzumab/DSTP-3086S/DSTP3086S/MSTP2109A/RG-7450/RG7450/STEAP1/anti-STEAP1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression